Search results
Showing: 10 of 364
Drug Tariff deduction scale
This is an update on behalf of the Department of Health and Social Care.
From 1 April 2023, products granted a concessionary price will no longer be subjected to the branded discount deduction rate but will be classified as 'Discount Not Deducted'…
NHS Lateral Flow Device (LFD) tests supply service for patients potentially eligible for COVID-19 treatments
The NHS LFD tests supply service for patients potentially eligible for COVID-19 treatments started on 6 November 2023.
Aims of the service
To offer eligible at-risk patients access to LFD tests to enable testing at home for COVID-19, if they…
Drug Tariff news - May Part VIIIA reimbursement prices
The Department of Health has agreed that the May Drug Tariff Part VIIIA reimbursement prices for the following items will be:
Baclofen 10mg tablets £7.20
Clonidine 25microgram tablets £9.00
Digoxin 125microgram tablets £4.99
Digoxin…
Drug Tariff News - November Part VIIIA reimbursement prices
The Department of Health has agreed that the November Drug Tariff Part VIIIA reimbursement price for the following items will be:
Amitriptyline 50mg tablets £3.25
Bumetanide 1mg tablets £1.95
Candesartan 2mg tablets £2.25
Dapsone 50mg tablets…
Drug Tariff News - November Part VIIIA reimbursement prices
The Department of Health has agreed that the November Drug Tariff Part VIIIA reimbursement price for the following items will be:
Amitriptyline 50mg tablets £3.25
Bumetanide 1mg tablets £1.95
Candesartan 2mg tablets £2.25
Dapsone 50mg tablets…
Drug Tariff News - January Part VIIIA Reimbursement Prices
The Department of Health has agreed that the January Drug Tariff Part VIIIA reimbursement price for
Amitriptyline 50mg tablets £3.40
Buspirone 5mg tablets £19.54
Candesartan 2mg tablets £2.25
Dapsone 50mg tablets £46.19
Exemestane 25mg…
Drug Tariff News - February Part VIIIA reimbursement prices
The Department of Health has agreed that the February Drug Tariff Part VIIIA reimbursement prices for the following items will be:
Amitriptyline 50mg tablets £3.50
Candesartan 2mg tablets £2.25
Dapsone 50mg tablets £46.19
Exemestane 25mg…
eRD information for pharmacies
Our GP Assurance team is working in collaboration with Primary Care Networks, Integrated Care Boards (ICBs) and Health Innovation Networks to help prescribers and dispensers realise the benefits of increased electronic Repeat Dispensing (eRD) use…
Complete the Community Pharmacy Assurance Framework screening questionnaire
We're reminding pharmacy contractors to complete this year's Community Pharmacy Assurance Framework (CPAF) screening questionnaire by 11:59pm on Saturday 24 July 2021.
Around 2,000 pharmacies still need to complete this year’s CPAF, which is…
2022 PhAS Review – application window
The 2022 PhAS started on 1 January 2022 with payments for the 2022 PhAS made with the reconciliation payment from 1 April 2022.
Contractors can apply for review of their PhAS eligibility as set out in the Pharmacy Access Scheme guidance. The review…